APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +25.0% ·
flujo de acciones -3.8% ·
nuevas posiciones netas +20.0%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 15.57M | -5.0% | $448.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 1.81M | +1.3% | $52.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 1.81M | +1.3% | $52.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (pasivo) | 1.07M | -1.1% | $30.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 817.26K | +231.0% | $23.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 817.26K | +231.0% | $23.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 817.26K | +231.0% | $23.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 378.46K | -70.3% | $10.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 378.46K | -70.3% | $10.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 372.33K | Nuevo | $10.74M | 0.0% | New | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 198.13K | +28.8% | $5.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 198.13K | +28.8% | $5.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Millennium Management ✦ | 77.39K | -62.4% | $2.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 58.78K | +113.4% | $1.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 21.79K | Nuevo | $628,424 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Renaissance Technologies | $10.74M | 0.0% |
| Marshall Wace | $628,424 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 320 tenedores, 137.95M acciones, $5.43B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.